United States · FDA National Drug Code directory
ATORVASTATIN CALCIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-744_5866cff8-7c35-4050-a75f-5e235b9d39b2
- Product NDC
- 71610-744
- Form
- TABLET, FILM COATED
- Composition / generic term
- ATORVASTATIN CALCIUM
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230810
- Source listing expiry
- 20261231
Source-listed ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET, FILM COATED in 1 BOTTLE (71610-744-15) · 71610-744-15
- 30 TABLET, FILM COATED in 1 BOTTLE (71610-744-30) · 71610-744-30
- 45 TABLET, FILM COATED in 1 BOTTLE (71610-744-45) · 71610-744-45
- 60 TABLET, FILM COATED in 1 BOTTLE (71610-744-53) · 71610-744-53
- 90 TABLET, FILM COATED in 1 BOTTLE (71610-744-60) · 71610-744-60
- 120 TABLET, FILM COATED in 1 BOTTLE (71610-744-70) · 71610-744-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →